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Introduction {#sec001}
============

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, with a mortality rate of approximately one million each year \[[@pone.0139232.ref001], [@pone.0139232.ref002]\]. The prognosis of HCC remains poor even with a combination of chemotherapies and radiation therapies because of intrinsic and/or acquired treatment resistance and a high rate of metastasis \[[@pone.0139232.ref003], [@pone.0139232.ref004]\]. Thus, a better understanding of the biochemical and molecular properties of HCC may lead to the development of biomarkers and therapeutic strategies. Differentiation is an important cellular process that regulates the clonal increase of the cell population, and the differentiation status of a cancer cell is known to play a pivotal role in the extent of carcinogenesis and its metastatic propensity \[[@pone.0139232.ref005]\]. Thus, the identification of molecules that determine the differentiation status (i.e., mesenchymal or epithelial) of HCC may provide important clues for drug development.

The differentiation of human hepatocytes is particularly interesting because varieties of plasma protein markers have been well characterized \[[@pone.0139232.ref006]--[@pone.0139232.ref008]\]. Because HCC is a hepatocyte malignancy, Chang et al. previously proposed that the expression patterns of plasma proteins and/or plasma membrane protein markers could be used as an approach for studying human HCC differentiation status \[[@pone.0139232.ref009]\]. However, this technique, although specific, is laborious and time-consuming because of the necessity of analyzing at least 15 different plasma proteins secreted in the culture medium. Subsequently, some independent differentiation-associated biomarkers have been discovered \[[@pone.0139232.ref010]--[@pone.0139232.ref013]\], but their clinical significance has not been verified thus far.

The current interest in proteomics has arisen in part because of the prospect that a proteomic approach to disease investigation may overcome some of the limitations encountered by other methodologies \[[@pone.0139232.ref014], [@pone.0139232.ref015]\]. With this premise in mind, we aimed to identify protein biomarkers in different components of HCC cells with distinct disparities in differentiation status. The rationale for this approach is that protein expression during cell differentiation may vary among different compartments (cytosol, nucleus and membrane fractions) of HCC cells. Some of these proteins may play pivotal roles in controlling the proliferative capability and metastatic behaviors. Furthermore, the translocation of proteins to the nucleus may also be crucial in initiating various biological events. In this study, we examined the protein expression in different cellular compartments and identified candidate proteins that were overexpressed or down-regulated in two HCC cell lines with distinct differentiation states. The identified proteins and their proposed functions may provide important information for therapeutic designs and may serve as potential biomarkers for predicting disease progression or treatment responses.

Materials and Methods {#sec002}
=====================

Origin and characteristics of HCC cells used in this study {#sec003}
----------------------------------------------------------

A panel of five HCC subline variants was selected for this study, and their differentiation statuses were established based on their morphological characteristics, secreted plasma protein profiles, pattern of lactate dehydrogenase (LD) isoenzyme expression\[[@pone.0139232.ref011]\], pattern of thyroid hormone β1 nuclear receptor (h-TRβ1) expression and pattern of hepatocyte-derived growth factor (HDGF) expression \[[@pone.0139232.ref016]\]. The HepG2 subline, a well-differentiated HCC variant, and the SK-Hep--1 subline, a poorly-differentiated HCC variant, were selected for proteomic analysis.

Cell culture {#sec004}
------------

HepG2, Hep3B, and SK-Hep--1 cells were purchased from ATCC. HepJ5 and Mahlavu cell were gifted from Dr. C.S Yang, National Taiwan University and Dr. C. P. Hu, Veterans General Hospital, Taiwan \[[@pone.0139232.ref017], [@pone.0139232.ref018]\]. Those cells were cultured in Dulbecco's modified Eagle medium (DMEM) (Sigma Chemical Co., St. Louis. MO, USA) supplemented with 10% fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT, USA) and incubated at 37°C in a humidified atmosphere with 5% CO~2~.

Two-dimensional electrophoresis {#sec005}
-------------------------------

Cultured cells were solubilized in lysis buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 1% IPG buffer, pH3-10 (GE Healthcare Life Sciences, Piscataway, NJ, USA), 65 mM DTT, and 10 nM PMSF. The protein concentration was measured using the Bradford assay (Bio-Rad, Hercules, CA, USA). Proteins were applied onto isofocusing gels (13-cm IPG linear strip, GE Healthcare Life Sciences, Piscataway, NJ, USA). The running conditions for the IEF were as follows: 30 V for 12 h, 100 V for 0.5 h, 250 V for 0.5 h, 500 V for 0.5 h, 1000 V for 0.5 h, 2000 V for 0.5 h, 4000 V for 0.5 h, and 8000 V for 0.5 h, up to 70 kV-h. IPG strips were equilibrated for 10 min in a solution containing 50 mM Tris-HCl (pH8.8), 6 M urea, 20% SDS, 30% glycerol, 2% DTT, and a trace of bromophenol blue, followed by 10 min in the same solution except that DTT was replaced with 2.5% iodoacetamide. The IPG gel strips were embedded in gels containing 0.5% agarose. 2-D SDS-PAGE was performed on 12% acrylamide gels (GE Healthcare, USA) at 6 mA/gel until the bromophenol blue dye front reached the bottom of the gel. After approximately 16--18 h, all gels were visualized using a mass-compatible silver stain and scanned using an image scanner (GE Healthcare, USA). Protein spots were quantified using Nonlinear Progenesis software (technical support provided by J&H Technology, Taipei, Taiwan). All experiments were repeated at least three times.

Tryptic in-gel digestion of proteins and MALDI-TOF MS {#sec006}
-----------------------------------------------------

Selected protein targets of approximately 1 mm in diameter on the 2-D gels were manually excised. Spots excised from the stained gels were processed according to the standard MS sample preparation protocol \[[@pone.0139232.ref019], [@pone.0139232.ref020]\]. In-gel digestion of proteins was performed using MS-grade Trypsin Gold (Promega, Madison, WI) overnight at 37°C. Tryptic digests were extracted using 10 μL Milli-Q water initially, followed by two extractions with a total of 20 μL of 50% acetonitrile / 0.1% trifluoroacetic acid. The combined extracts were dried in a vacuum concentrator at room temperature and dissolved in 1 μL of 5% acetonitrile with 0.5% trifluoroacetic acid. The ESI-MS/MS mass spectrometer utilized for protein analysis was a Thermo LTQ-Orbitrap (Thermo Scientific, UK). The MS/MS signal was analyzed using the MASCOT search engine ([www.matrixscience.com](http://www.matrixscience.com/)). The search parameters were defined as follows: database, NCBInr 20120129; taxonomy, viridiplantae (Green Plants); enzyme, trypsin; fixed modification, carbamidomethylation; variable modifications, oxidation; peptide MS tolerance, ± 0.5 Da; and fragment MS tolerance, ± 0.5 Da and allowance of one missed cleavage.

Separation of proteins from HCC compartments and western blotting {#sec007}
-----------------------------------------------------------------

Subcellular fractions were prepared using the Pierce Cytoplasmic Nuclear extraction kit (Thermo, USA). In brief, harvested cells were resuspended with CERI and CERII and centrifuged at 16000x g for 5 min, and the cytoplasmic fraction (supernatant) was separated from the nuclei (pellet). Subsequently, the pellet was resuspended with NER. After centrifugation at 16000x g for 10 min, the supernatant was collected as the nuclear fraction. 2-DE lysis buffer with 8 M urea and 4% CHAPS was added to the remaining pellet to isolate the membrane fraction. The protein samples were separated using SDS-PAGE and analyzed via immunoblotting. The primary antibodies used targeted vimentin, Annexin1 (ANX1), ANX4, and heat shock protein--27 (HSP27) (1:1000; Santa Cruz Biotech., Santa Cruz, CA, USA). Enhanced chemiluminescence (Immobilon Western Chemiluminescent AP substrate or ECL reagent, Millipore, Billerica, MA, USA) was used for detection. Expression of β-actin was used to control for equal gel loading.

Immunofluorescence staining {#sec008}
---------------------------

Approximately 1×10^5^ cells were seeded in 6-well culture plates. When the cells were 50--60% confluent, they were fixed in an iced acetone and methanol 1:1 (v/v) mixed solution for 15 min. The cells were permeabilized with PBS containing 1% (v/v) Triton X--100 and incubated with primary antibodies. To detect primary antibody binding sites, the plates were washed and stained with FITC-conjugated secondary antibodies. After washing in PBS, propidium iodide (PI) was added as a nuclear counterstain. The cells were visualized using a fluorescence microscope (Nikon).

Gene silencing {#sec009}
--------------

Expression of ANX1 and HSP27 in HCC cells was ablated using Mission shRNA clones from Sigma Chemical Co. (St. Louis, MO). Mission shRNA clones are sequence-verified shRNA lentiviral plasmids purchased from the National RNAi Core Facility (Taiwan, ROC) for gene silencing in mammalian cells. The parental vector (pLKO.1\<-puro) enables transient transfection or stable selection through puromycin resistance. The target sequence for the human ANXA1 mRNA (NM_000700.1) gene was 5'-CATAAGGCCATAATGGTTAAA--3'. The target sequence for the human HSP27 mRNA (NM_001540.3) gene was 5'-CCGATGAGACTGCCGCCAAGT--3'. The non-target shRNA control vector (SHC002) was purchased from Sigma Chemical Co. (St. Louis, MO), and the sequence of scrambled shRNA was 5'-CAACAAGATGAAGAGCACCAA--3'. Briefly, 1.5×10^5^ cells were washed twice with PBS and mixed with 0.5 μg of the plasmid. One pulse was applied for 20 ms under a fixed voltage of 1.4 kV on a pipette-type Neon microporator (Life Technologies). Stably transfected cells were selected by puromycin for 2 weeks. The expression level of ANX1 and HSP27 was determined by real-time PCR and western blotting.

Transwell migration assay {#sec010}
-------------------------

In vitro cell migration studies were performed using a BD Falcon cell culture insert (BD Biosciences, Durham, NC) as previously described \[[@pone.0139232.ref021]\]. Briefly, we suspended 1×10^5^ cells in 500 μL of serum-free DMEM, and the cells were seeded into the upper part of each chamber. The lower compartment of each chamber was filled with 1 mL of DMEM that contained a 10% FCS serum gradient. After incubation for 24 hours at 37°C in 5% CO~2~, the non-migrating cells were removed from the upper surface of the membrane by scraping. Cells on the reverse side of the membrane were stained with 0.1% crystal violet. The migrating cells were counted under a microscope at 100-fold magnification.

Real-time quantitative reverse transcription-PCR (qRT-PCR) analysis {#sec011}
-------------------------------------------------------------------

Total RNA was isolated from colon cancer cells using Trizol reagent according to the manufacturer's instructions (Invitrogen Life Technologies). The cDNA was amplified from 2 μg of total RNA in a final volume of 20 μL using Moloney murine leukemia virus (M-MLV) reverse transcriptase at 37°C for 90 min. The sequences of the qPCR primers were 5'-CCCCCATGCCCAAGCTA -3' (forward) and 5'-TCGAAGGTGACTGGGATGGT -3' (reverse) for HSP27, 5'-AAAGGTGGTCCCGGATCAG -3' (forward) and 5'-CATCCACACCTTTAACCATTATgg -3' (reverse) for ANX1, 5\'-AGCGCGGCTACAGCT--3\'(forward) and 5'-GGCCATCTCTTGCTCGAAGT--3' (reverse) for β-actin. The quantitative RT-PCR reaction was performed using ABI SYBR Green Master Mix using in an ABI StepOne system (Applied Biosystems, Grand Island, NY). Thermal cycling was performed in the ABI StepOne system. The quantitative PCR conditions were 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The cycle parameters were 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds, 60°C for 1 minute, and a final extension at 72°C for 10 minutes.

Tissue microarray staining by HSP27 and ANX1 {#sec012}
--------------------------------------------

Tissue microarray sets totally including 80 cases of primary HCC (catalog No. CSA4 and CS4) were purchased from SuperBioChips Laboratories. (Seoul, South Korea). The pathologic diagnosis and tumor grading of these cases were microscopically reconfirmed by a pathologist. The grading system of World Health Organization was used. HCC was divided into well-differentiated (WD), moderately differentiated (MD) and poorly differentiated (PD). An immunohistochemical stain with HSP27 (catalog No.: ab2790. 1:750; Abcamplc, Cambridge, United Kingdom) was performed. Expression levels of HSP27 were scored semiquantitatively as weakly positive (1+), moderately positive (2+) and strongly positive (3+). To understand the correlation between pathologic characteristics and expression levels of ANX1, two tissue microarray sets totally including 88 cases of HCC (catalog No. CSA4 and CS5) were purchased from SuperBioChips Laboratories. An immunohistochemical stain with ANX1 (clone: MRG3. 1:150; Cell Marque Corp., Rocklin, California, USA) was performed. Expression levels of ANX1 were scored semiquantitatively as negative, weakly positive and strongly positive. The association between pathologic characteristics and ANX1 expression was analyzed.

Statistical analysis {#sec013}
--------------------

All experiments were repeated a minimum of three times. All data collected from real-time RT-PCR analysis, MTT assays and migration assays are expressed as the mean ± SD. The data presented in some figures are from a single experiment that was quantitatively similar to the replicate experiments. Statistical significance was determined using Student's t test (two-tailed) or chi-square test to compare two groups of data sets.

Results {#sec014}
=======

Identification of abundantly expressed proteins in HCC cells {#sec015}
------------------------------------------------------------

Approximately 450 μg of the total protein obtained from total cell lysates of either HepG2 or SK-Hep--1 cells was focused by IEF on pH 3--10 nonlinear IPG strips before being separated on a 12% polyacrylamide gel (PAGE). The spots were visualized by Coomassie blue G250 staining. Among the 60 spots that were identified, 46 were associated with HepG2 cells, and 14 spots belonged to SK-Hep--1 cells. Protein spots of interest were analyzed using MALDI-TOF and the MALDI spectra followed by identification using the MASCOT search engine. The MALDI-TOF identification of the protein spots from the lysates of HCC sublines is presented in [Fig 1A](#pone.0139232.g001){ref-type="fig"} and [Table 1](#pone.0139232.t001){ref-type="table"}. We also isolated proteins from various cellular compartments of HepG2 and SK-Hep--1 cells. Cytosolic (500 μg), nuclear (250 μg) and membrane (250 μg) proteins were then subjected to IEF followed by PAGE. Protein spots were identified by MALDI-TOF, as indicated in **[Fig 1B, 1C and 1D](#pone.0139232.g001){ref-type="fig"}** and **Tables [2](#pone.0139232.t002){ref-type="table"}, [3](#pone.0139232.t003){ref-type="table"} and [4](#pone.0139232.t004){ref-type="table"}**. Among the abundantly expressed protein spots on the 2-DE map (161 spots), a total of 106 spots (64%) belonged to the well-differentiated HepG2 cells, with the following order of distribution in each cellular compartment: total cell lysate (46; 46%)\>cytosol (35; 33%)\>membrane (13; 12%)\>nucleus (12; 11%) (**[Fig 2](#pone.0139232.g002){ref-type="fig"} and Tables [2](#pone.0139232.t002){ref-type="table"}, [3](#pone.0139232.t003){ref-type="table"} and [4](#pone.0139232.t004){ref-type="table"}**). Conversely, a total of 55 spots (36%) belonged to the poorly differentiated SK-Hep--1 cells, with the following order of abundance in each cellular compartment: nucleus (18; 33%)\>cytosol (16; 29%)\>total cell lysate (14; 25%)\>membrane (7; 13%) (**[Fig 2](#pone.0139232.g002){ref-type="fig"} and Tables [2](#pone.0139232.t002){ref-type="table"}, [3](#pone.0139232.t003){ref-type="table"} and [4](#pone.0139232.t004){ref-type="table"}**). Notably, the well-differentiated HCC cells overexpressed antioxidant/metabolic enzymes, such as MnSOD, peroxiredoxin (Prdx), NADP-dependent isocitrate dehydrogenase (ICDH), α-enolase and UDP-glucose dehydrogenase. In contrast, poorly differentiated HCC cells exhibited high levels of stress-associated proteins, such as Grp78, HSP75, HSC--70, protein disulfide isomerase (PDI), and HSP27 (**Tables [5](#pone.0139232.t005){ref-type="table"} and [6](#pone.0139232.t006){ref-type="table"}**).

![Representative 2D gel images of various cellular compartments depicting identified protein spots that were differentially expressed between HepG2 and SK-Hep--1 clonal variants.\
(A) Total cell lysate, (B) cytosol, (C) nucleus, and (D) membrane. Differentially expressed proteins are numbered and boxed. Reference proteins are indicated by arrowheads.](pone.0139232.g001){#pone.0139232.g001}

![Protein classification.\
The functional classifications of the identified proteins.a: Cell cycle: 3%; b: chaperone/stress response: 9%; c: cytoskeleton/ cell mobility: 15%; d: DNA replication/gene regulation/cell proliferation: 12%; e: ion channels: 2%; f: membrane proteins: 4%; g: metabolic enzyme: 16%; h: protection and detoxification: 6%; i: protein synthesis and degradation: 8%; j: signal transduction: 8%; k: transport/binding proteins: 6%; l: intermediate filaments: 15%; and m: unannotated/ function inferred: 4%.](pone.0139232.g002){#pone.0139232.g002}

10.1371/journal.pone.0139232.t001

###### Total proteins of HepG2 and SK-Hep--1 cells were identified by MALDI-TOF.

![](pone.0139232.t001){#pone.0139232.t001g}

  --------------- -------------- ------------------- ----------------------------------------------- -------------------------- --------------------- ----------------------------- ----------------------------------------------------------- ------------
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                              **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**     **Molecular function**                                      **Class.**
  **HepG2**                                                                                                                                                                                                                                     
                  1                                  Dnak-type molecular chaperone HSPA5             72.185/5.03                188(61%)                                            Chaperone                                                   b
                  2                                  Dnak-type molecular chaperone HSPA5             72.185/5.03                256(62%)                                            Chaperone                                                   b
                  3                                  Dnak-type chaperone precursor                   73.92/5.87                 200(61%)                                            Chaperone                                                   b
                  4                                  Dnak-type chaperone precursor                   71.082/5.37                141(56%)                                            Chaperone                                                   b
                  5              P61978              Heterogeneous nuclear ribonucleoprotein K       47.756/5.46                102(46%)              Nucleus/ cytoplasm            Regulation of transcription                                 d
                  6              P10809              HSP 60A                                         61.157/5.70                188(71%)              Mitochondrial matrix          Transport the mitochondrial proteins                        b
                  7              NP 00684            Protein disulfide-isomerase (ER60)              57.48/4.76                 179(64%)              ER lumen                      Folding of proteins containing disulfide bonds in ER        h, i
                  8              NP 00684            Protein disulfide-isomerase (ER60)              57.146/5.98                189(60%)              ER lumen                      Folding of proteins containing disulfide bonds in ER        i
                  9              NP 057078           H^+^-transporting two-sector ATPase             56.525/5.26                145(77%)              Mitochondrion                 ATP synthesis coupled proton transport                      c, l
                  10             P17980              Proteasome subunit p50                          49.458/5.13                88(60%)               Nucleus/ cytoplasm            Ubiquitin-dependent Protein catabolism                      i
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                              **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**     **Molecular function**                                      **Class.**
  **HepG2**       11             P31948              Stress induced phosphoprotein1 (STI 1)          65.089/6.27                139(66%)              Nucleus/ cytoplasm            Modulation the molecular chaperones HSC 70 and HSP 90       b
                  12             NP 000680           Aldehyde dehydrogenase 1A1                      55.454/6.30                106(67%)              Cytoplasm                     Alcohol metabolic enzyme                                    g
                  13             P78371              T complex protein 1 subunit beta                57.794/6.01                185(79%)              Cytoplasm                     Chaperone                                                   b
                  14             P06733              α-enolase                                       47.35/6.99                 230(76%)              Cytoplasm                     Metabolic enzyme (Glycolysis)                               g
                  15             NP 005887           NADP-dependent isocitrate dehydrogenase         46.944/6.34                149(75%)              Mitochondrial matrix          Metabolic enzyme (TCA cycle)                                g
                  16             NP 001606           Actin-gamma                                     42.108/5.31                124(82%)              Cytoplasm                     Cytoskeleton, cell motility                                 c, l
                  17             P42330              Aldo-keto reductase                             37.23/8.06                 81(61%)               Cytoplasm                     Aldehyde metabolism                                         g
                  18             P42330              Aldo-keto reductase family 1                    36.20/6.76                 62(61%)               Cytoplasm                     Aldehyde metabolism                                         g
                  19             P50225              Aryl sulfotransferase                           34.288/5.68                127(84%)              Cytoplasm                     Amine biosynthesis                                          g
                  20             P07951              Tropomyosin                                     28.89/4.76                 52(20%)               Cytoplasm                     Cytoskeleton, regulation of muscle contraction              g
                  21             P35232              Prohibitin                                      29.589/5.57                214(83%)              Mitochondria inner membrane   Gene regulation and modulate the cell proliferation         d
                  22             P60174              Triosephosphate isomerase                       26.807/6.51                127(84%)                                            Metabolic enzyme (Glycolysis)                               g
                  23                                 ER lumenal 28                                   29.032/6.77                80(61%)                                                                                                         m
                  24                                 ER lumenal 28                                   29.032/6.77                75(57%)                                                                                                         m
                  25             P30086              PEBP                                            21.027/7.42                81(81%)               Cytoplasm                     Regulation of central nervous system                        k
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                              **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**     **Molecular function**                                      **Class.**
  **HepG2**       26             P32119              Peroxiredoxin II                                21.92/5.67                 74(49%)               Cytoplasm                     Antioxidant enzyme                                          h
                  27             NP 000260           NM23-H1                                         19.869/5.42                113(60%)              Nucleus/ cytoplasm            Modulate the cell proliferation and nucleotide metabolism   c, d
                  28                                 ND                                                                                                                                                                                         
                  29             P52945              Insulin activator factor                        83.906/5.6                 69(20%)               Nucleus                       Activate insulin                                            g
                  30                                 ND                                                                                                                                                                                         
                  31             P60174              Triosephosphate isomerase (TIM)                 26.807/6.51                150(76%)              Cytoplasm                     Metabolic enzyme (Glycolysis)                               g
                  32             P25786              Proteasome (macropain), α-type 1                29.864/6.15                86(40%)               Nucleus/ cytoplasm            Ubiquitin-dependent protein catabolism                      i
                  33                                 Enoyl-CoA hydratase                             31.807/8.34                167(73%)                                                                                                        m
                  34             NP 002119           High-mobility group box 1                       18.470/9.72                72(44%)               Nucleus                       Gene regulation                                             d, h
                  35             P52895              3-α-hydroxysteroid/ dihydrodiol dehydrogenase   37.221/8.02                239(85%)              Cytoplasm                     Steroid metabolism                                          g
                  36             P42330              Aldo-keto reductase family 1                    36.226/7.12                155(70%)              Cytoplasm                     Aldehyde metabolism                                         g
                  37                                 ND                                                                                                                                                                                         
                  38             P10809              GroEL (HSP 60)                                  61.187/5.70                139(54%)              Mitochondrial matrix          Transport the mitochondrial proteins                        b
                  39             P10809              GroEL (HSP 60)                                  61.187/5.70                139(54%)              Mitochondrial matrix          Transport the mitochondrial proteins                        b
                  40             NP 777480           TGF-β receptor interacting protein 1            36.878/5.38                103(57%)              Nucleus                       Gene regulation                                             d
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                              **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**     **Molecular function**                                      **Class.**
  **HepG2**       41             NP 002264           Keratin 8                                       41.083/4.94                159(72%)              Intermediate filament         Cytoskeleton organization and biogenesis                    c
                  42             P27797              Calreticulin variant                            47.061/4.30                120(38%)              ER                            Protein folding                                             i
                  43             NP 005887           NADP-dependent isocitrate dehydrogenase         46.931/6.53                144(66%)              Mitochondrial matrix          Metabolic enzyme (TCA cycle)                                g
                  44             P06733              α-enolase                                       47.35/6.99                 288(73%)              Cytoplasm                     Metabolic enzyme (Glycolysis)                               g
                  45             NP 003350           UDP-glucose dehydrogenase                       55.674/6.73                225(77%)              Cytoplasm                     Metablolic enzyme (Glycosaminoglycan biosynthesis)          g
                  46             P09525              Annexin A4                                      33.759/5.64                60(32%)               Mitochondrion                 Calcium binding protein                                     e, f, l
  **SK-Hep--1**                                                                                                                                                                                                                                 
                  47             P11021              Grp 78                                          72.402/5.07                250(57%)              ER lumen                      Protein folding in ER                                       i
                  48             Q12931              HSP 75                                          74.02/5.97                 274(64%)              Mitochondrion                 Expression an ATPase activity                               b
                  49             P11142              Heat-shock cognate protein 70                   71.082/5.37                119(53%)              Nucleus/ cytoplasm            Chaperone                                                   b
                  50             P10809              Chaperonin                                      61.187/5.70                212(77%)              Mitochondrial matrix          Transport the mitochondrial proteins                        b
                  51             P31948              Stress induced phosphoprotein1 (STI 1)          63.227/6.40                164(56%)              Nucleus/ cytoplasm            Modulation the molecular chaperones HSC 70 and HSP 90       b
                  52             NP 00684            Protein disulfide isomerase (PDI)               57.48/4.76                 208(65%)              ER lumen                      Folding of proteins containing disulfide bonds in ER        h, i
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                              **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**     **Molecular function**                                      **Class.**
  **SK-Hep--1**   53             P06733              α-enolase                                       47.35/6.99                 219(72%)              Cytoplasm                     Metabolic enzyme (Glycolysis)                               g
                  54             AAH01751            Chromosome 20 open reading frame 4              43.843/5.66                59(31%)               Cytoplasm                     cell growth                                                 d
                  55             P33992              Replication licensing factor, MCM5              82.990/8.56                83(33%)               Nucleus                       Initiation of DNA replication                               d
                  56             NP 001606           Actin-gamma                                     42.108/5.31                118(72%)              Cytoplasm                     Cytoskeleton, cell motility                                 c, l
                  57             P06753              Tropomyosin3                                    32.856/4.72                87(58%)               Cytoplasm                     Cytoskeleton, regulation of muscle contraction              c, l
                  58             P06753              Tropomyosin3                                    27.386/4.77                100(51%)              Cytoplasm                     Cytoskeleton, regulation of muscle contraction              c, l
                  59             P18669              Phosphoglycerate mutase B                       28.90/6.67                 141(81%)              Cytoplasm                     Metabolic enzyme (Glycolysis)                               g
                  60             P60174              Triosephosphate isomerase (TIM)                 26.807/6.51                112(82%)              Cytoplasm                     Metabolic enzyme (Glycolysis)                               g
  --------------- -------------- ------------------- ----------------------------------------------- -------------------------- --------------------- ----------------------------- ----------------------------------------------------------- ------------

ND: None detected.

**The functional classification (Class)** of identified proteins is shown a \~ m. a: cell cycle; b: chaperone/ stress response; c: cytoskeleton/ cell mobility; d: DNA replication/ gene regulation/ cell proliferation; e: ion channels; f: membrane proteins; g: metabolic enzyme; h: protection and detoxification; i: protein synthesis and degradation; j: signal transduction; k: transport/ binding proteins; l: intermediate filaments; m: unannotated/ function inferred.

10.1371/journal.pone.0139232.t002

###### Cytosolic fraction proteins of Hep G2 and SK-Hep--1 cells were identified by MALDI-TOF.

![](pone.0139232.t002){#pone.0139232.t002g}

  --------------- -------------- ------------------- -------------------------------------------------- -------------------------- --------------------- --------------------------- ------------------------------------------------------ ------------
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                 **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**   **Molecular function**                                 **Class.**
  **HepG2**                                                                                                                                                                                                                                 
                  1              NP 00067            Mn SOD                                             22.304/6.86                105(64%)              Mitochondrion               Antioxidant activity                                   h
                  2              NP 859048           Peroxiredoxin I                                    14.054/6.25                85(73%)               Mitochondrion               Antioxidant activity                                   h
                  3                                  ND                                                                                                                                                                                     
                  4              P32119              Peroxiredoxin II                                   21.918/5.67                106(62%)              Cytoplasm                   Antioxidant activity                                   h
                  5              P27797              Calreticulin variant                               47.061/4.30                181(60%)              ER                          Protein folding                                        i
                  6              P27797              Calreticulin variant                               47.061/4.30                248(67%)              ER                          Protein folding                                        i
                  7              P27797              Calreticulin variant                               47.061/4.30                182(54%)              ER                          Protein folding                                        i
                  8              P06753              Tropomyosin                                        27.387/4.71                156(52%)              Cytoplasm                   Cytoskeleton, regulation of muscle contraction         c, l
                  9              P12004              PCNA                                               29.092/4.57                91(63%)               Nucleus                     Cell cycle regulation                                  a, d
                  10             P06748              Nucleophosmin, B23                                 31.090/4.71                68(40%)               Nucleus                     Regulate cell proliferation                            a
                  11             P52895              3-α-hydroxysteroid/ dihydrodiol dehydrogenase      37.221/8.02                114(66%)              Cytoplasm                   Steroid metabolism                                     g
                  12             P09525              Annexin A4                                         35.957/5.85                151(67%)              Mitochondrion               Calcium binding protein                                e, f, l
                  13             P30041              Peroxiredoxin VI                                   25.002/6.02                92(61%)               Cytoplasm                   Antioxidant activity                                   h
                  14             P04792              HSP 27                                             22.427/7.83                99(63%)               Nucleus/ Cytoplasm          Protein folding                                        b
                  15             P60174              Triosephosphate isomerase (TIM)                    26.807/6.51                169(79%)              Cytoplasm                   Metabolic enzyme (Glycolysis)                          g
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                 **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**   **Molecular function**                                 **Class.**
  **HepG2**       16             P18669              Phosphoglycerate mutase 1                          28.769/6.75                153(79%)              Cytoplasm                   Metabolic enzyme (Glycolysis)                          g
                  17             P42330              Aldo keto reductase                                36.226/7.12                115(67%)              Cytoplasm                   Aldehyde metabolism                                    g
                  18             NP 002037           Glucose 3 phosphate dehydrogenase                  36.202/8.26                112(64%)              Cytoplasm                   Metabolic enzyme (Glycolysis)                          g
                  19             P52895              3-α-hydroxysteroid/ dihydrodiol dehydrogenase      37.221/8.02                114(66%)              Cytoplasm                   Steroid metabolism                                     g
                  20             NP 005887           Isocitrate dehydrogenase                           46.944/6.34                147(72%)              Mitochondrial matrix        Metabolic enzyme (TCA cycle)                           g
                  21             P06733              α-enolase                                          47.35/6.99                 288(73%)              Cytoplasm                   Metabolic enzyme (Glycolysis)                          g
                  22             P05783              Cytokeratin 18                                     47.305/5.27                268(69%)              Cytoplasm                   Cytoskeleton                                           c
                  23             NP 003290           Tumor rejection antigen, gp96                      92.567/4.77                244(55%)              Cytoplasm                   Protein folding and transport                          h
                  24             P19338              Nucleolin                                          58.576/4.57                96(32%)               Nucleus                     DNA/ RNA binding                                       d
                  25             NP 003290           Tumor rejection antigen, gp96                      92.567/4.77                244(55%)              Cytoplasm                   Protein folding and transport                          h
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                 **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**   **Molecular function**                                 **Class.**
  **HepG2**       26             P38646              Grp 75                                             74.019/5.97                271(58%)              Mitochondrion               Cell proliferation and Cellular aging                  d
                  27             NP 004125           HSP 70k 9B (mortalin--2)                           74.093/6.04                268(58%)              Cytoplasm                   Anti-apoptosis, protein folding                        b
                  28             NP 003350           UDP-glucose dehydrogenase                          55.674/6.73                298(75%)              Cytoplasm                   Metablolic enzyme (Glycosaminoglycan biosynthesis)     g
                  29             P00352              Retinal dehydrogenase (AL1A1)                      55.323/6.29                112(53%)              Cytoplasm                   Metabolic enzyme (retinoic acid biosynthesis)          g
                  30             P60709              β-actin                                            42.08/5.37                 87(66%)               Cytoskeleton                Cytoskeleton                                           c, l
                  31             NP 001606           gamma-actin                                        42.108/5.31                165(77%)              Cytoplasm                   Cytoskeleton, cell motility                            c, l
                  32             NP 00684            Protein disulfide-isomerase (ER 60)                57.146/5.98                301(67%)              ER lumen                    Folding of proteins containing disulfide bonds in ER   h, i
                  33             P10809              Chaperonin GroEL procursor                         61.187/5.70                162(57%)              Mitochondrial matrix        Transport the mitochondrial proteins                   b, k
                  34             P11021              Grp 78                                             72.407/5.07                188(55%)              ER lumen                    Protein folding in ER                                  k
                  35             P31939              Bifunctional purine biosynthesis protein, PURH     64.938/6.39                268(74%)              Nucleus/ cytoplasm          Nucleic acid metabolism                                g
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                 **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**   **Molecular function**                                 **Class.**
  **SK-Hep--1**                                                                                                                                                                                                                             
                  36             P04406              Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)   36.202/8.26                112(64%)              Cytoplasm                   Metabolic enzyme (Glycolysis)                          g
                  37             P56876              Probable thioredoxin peroxidase (PAGA)             22.324/8.27                165(71%)              Nucleus/ cytoplasm          Antioxidant enzyme                                     h
                  38             P63104              14.3.3 protein zeta/delta                          30.10/4.72                 149(58%)              Cytoplasm                   Signal transduction                                    j
                  39             P31947              14.3.3 protein sigma (Stratifin)                   27.871/4.68                96(44%)               Cytoplasm                   Cell proliferation, signal transduction                a, d, j
                  40             P06753              Tropomyosin                                        27.387/4.71                120(50%)              Cytoplasm                   Cytoskeleton, regulation of muscle contraction         c, l
                  41             P07951              Tropomyosin                                        32.856/4.72                98(52%)               Cytoplasm                   Cytoskeleton, regulation of muscle contraction         c, l
                  42             P62258              14.3.3 protein epsilon                             29.326/4.63                137(66%)              Cytoplasm                   Signal transduction                                    j
                  43             P12004              PCNA                                               29.092/4.57                91(63%)               Nucleus                     Cell cycle regulation                                  a, d
                  44             BAA82513            Pre-mRNA splicing factor SP2p32                    31.287/4.74                73(61%)               Cytoplasm                   mRNA processing                                        d
                  45             P06748              B23                                                31.090/4.71                82(43%)               Nucleus                     Regulate cell proliferation                            a
                  46             P08670              Vimentin                                           53.545/5.06                283(72%)              Cytoskeleton                Cytoskeleton, cell motility                            c, f, l
                  47             P08670              Vimentin                                           53.545/5.06                306(71%)              Cytoskeleton                Cytoskeleton, cell motility                            c, f, l
                  48             P08670              Vimentin                                           53.464/4.99                281(80%)              Cytoskeleton                Cytoskeleton, cell motility                            c, f, l
                  49             NP 002264           Keratin 8                                          30.802/5.02                177(83%)              Intermediate filament       Cytoskeleton organization and biogenesis               c
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                 **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**   **Molecular function**                                 **Class.**
  **SK-Hep--1**   50             P10809              Chaperonin GroEL procursor                         61.187/5.70                162(57%)              Mitochondrial matrix        Transport the mitochondrial proteins                   b, k
                  51             NP 00684            Protein disulfide-isomerase                        57.480/4.76                267(69%)              ER lumen                    Folding of proteins containing disulfide bonds in ER   h, i
  --------------- -------------- ------------------- -------------------------------------------------- -------------------------- --------------------- --------------------------- ------------------------------------------------------ ------------

ND: None detected.

**The functional classification (Class)** of identified proteins is shown a \~ m. a: cell cycle; b: chaperone/ stress response; c: cytoskeleton/ cell mobility; d: DNA replication/ gene regulation/ cell proliferation; e: ion channels; f: membrane proteins; g: metabolic enzyme; h: protection and detoxification; i: protein synthesis and degradation; j: signal transduction; k: transport/ binding proteins; l: intermediate filaments; m: unannotated/ function inferred.

10.1371/journal.pone.0139232.t003

###### Nuclear fraction proteins of Hep G2 and SK-Hep--1 cells were identified by MALDI-TOF.

![](pone.0139232.t003){#pone.0139232.t003g}

  --------------- -------------- ------------------- --------------------------------------------------------- -------------------------- --------------------- ------------------------------ ------------------------------------------------------ ------------
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                        **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**      **Molecular function**                                 **Class.**
  **HepG2**                                                                                                                                                                                                                                           
                  1              P56876              Probable thioredoxin peroxidase (PAGA)                    22.324/8.27                165(71%)              Nucleus/ cytoplasm             Antioxidant enzyme                                     h
                  2              NP 002119           High-mobility group box 1                                 18.470/9.72                48(52%)               Nucleus                        Cell proliferation, anti-apoptosis                     d, h
                  3              NP 112533           Heterogeneous nuclear ribonucleoprotein B1                37.464/8.97                182(61%)              Nucleus                        Regulation of transcription                            d
                  4              P04406              Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)          36.07/8.58                 98(58%)               Cytoplasm                      Metabolic enzyme (Glycolysis)                          g
                  5              P07355              Annexin A2 (lipocortin II)                                38.677/7.56                216(67%)              Plasma membrane                Calcium binding protein                                e, f, l
                  6              P04083              Annexin A1 (lipocortin1)                                  38.787/6.64                202(64%)              Plasma membrane                Calcium binding protein                                e, f, l
                  7              P07355              Annexin A2 (lipocortin II)                                38.677/7.56                216(67%)              Plasma membrane                Calcium binding protein                                e, f, l
                  8              NP 003657           Basic leucine zipper nuclear factor 1 (JEM--1)            13.750/9.36                60(65%)               Nucleus/ cytoplasm             Cell proliferation and gene regulation                 d
                  9              P 24534             Elongation factor 1-β                                     24.788/4.50                56(41%)               Cytoplasm                      Regulate translation                                   d
                  10                                 ND                                                                                                                                                                                               
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                        **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**      **Molecular function**                                 **Class.**
  **HepG2**       11             P06748              Nucleophosmin, B23                                        29.617/4.47                69(38%)               Nucleus                        Regulate cell proliferation                            a
                  12             P33991              DNA replication licensing factor, MCM4                    97.068/6.28                43(13%)               Nucleus                        Initiation of DNA replication                          d
  **SK-Hep--1**                                                                                                                                                                                                                                       
                  13             NP 006146           Septin 2 (NEDD5)                                          36.824/6.85                74(33%)               Cytoplasm                      GTP binding                                            a, d
                  14             P02545              Lamin C                                                   65.153/6.40                254(67%)              Nucleus                        Protein binding                                        l
                  15             NP 002264           Keratin 8                                                 30.802/5.02                203(81%)              Intermediate filament          Cytoskeleton organization and biogenesis               c
                  16             NP 001034267        ATP sythase D chain, mitochondria                         18.405/5.22                62(53%)               Mitochondrion                  ATP synthesis                                          g
                  17             NP 031478           Peroxiredoxin III                                         28.047/7.11                63(52%)               Mitochondrion                  Antioxidant activity                                   h
                  18             P35232              Prohibitin                                                29.859/5.57                184(79%)              Mitochondrial inner membrane   Gene regulation and modulate the cell proliferation    d
                  19             NP 038470           Somatin-like protein 2 (SLP--2)                           38.642/6.88                132(69%)              Cytoskeleton                   Receptor binding                                       c, f
                  20             NP 00684            Protein disulfide-isomerase(ER 60)                        57.146/5.98                301(67%)              ER lumen                       Folding of proteins containing disulfide bonds in ER   h, i
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                                        **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**      **Molecular function**                                 **Class.**
  **SK-Hep--1**   21             NP 002264           Keratin 8 (fragment)                                      41.083/4.94                127(51%)              Intermediate filament          Cytoskeleton organization and biogenesis               c
                  22             NP 002264           Keratin 8 (fragment)                                      41.083/4.94                127(51%)              Intermediate filament          Cytoskeleton organization and biogenesis               c
                  23             P05783              Cytokeratin 18                                            47.305/5.27                268(69%)              Cytoplasm                      Cytoskeleton                                           c
                  24             NP 001677           H^+^-transporting two-sector ATPase, β chain              56.525/5.26                250(69%)              Mitochondrion                  ATP synthesis coupled proton transport                 k
                  25                                 Dnak-type molecular chaperone precursor HSPA5 precursor   72.185/5.03                288(50%)                                             Chaperone                                              b
                  26             P38646              Grp 75                                                    74.019/5.97                355(63%)              Mitochondrion                  Cell proliferation and Cellular aging                  d
                  27             P08670              Vimentin                                                  53.545/5.06                306(71%)              Cytoskeleton                   Cytoskeleton, cell motility                            c, f, l
                  28             P08670              Vimentin                                                  53.545/5.06                306(71%)              Cytoskeleton                   Cytoskeleton, cell motility                            c, f, l
                  29             P06733              α-enolase                                                 47.35/6.99                 128(58%)              Cytoplasm                      Metabolic enzyme (Glycolysis)                          g
                  30             P11021              Grp 78                                                    72.402/5.07                223(53%)              ER lumen                       Protein folding in ER                                  i
  --------------- -------------- ------------------- --------------------------------------------------------- -------------------------- --------------------- ------------------------------ ------------------------------------------------------ ------------

ND: None detected.

**The functional classification (Class)** of identified proteins is shown a \~ m. a: cell cycle; b: chaperone/ stress response; c: cytoskeleton/ cell mobility; d: DNA replication/ gene regulation/ cell proliferation; e: ion channels; f: membrane proteins; g: metabolic enzyme; h: protection and detoxification; i: protein synthesis and degradation; j: signal transduction; k: transport/ binding proteins; l: intermediate filaments; m: unannotated/ function inferred.

10.1371/journal.pone.0139232.t004

###### Membrane fraction proteins of Hep G2 and SK-Hep--1 cells were identified by MALDI-TOF.

![](pone.0139232.t004){#pone.0139232.t004g}

  --------------- -------------- ------------------- --------------------------------------------- -------------------------- --------------------- ------------------------------ ----------------------------------------------------- ------------
  **Cells**       **Spot NO.**   **Accession NO.**   **Identification**                            **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**      **Molecular function**                                **Class.**
  **HepG2**                                                                                                                                                                                                                              
                  1              NP 001034267        ATP synthase D chain                          18.405/5.22                80(68%)               Mitochondrion                  ATP synthesis                                         g
                  2              P35232              Prohibitin                                    29.859/5.57                135(73%)              Mitochondrial inner membrane   Gene regulation and modulate the cell proliferation   c, l
                  3              P06576              ATP synthase β-subunit                        34.026/4.90                61(50%)               Mitochondrion                  ATP synthesis                                         g
                  4              P06753              Tropomyosin3                                  27.386/4.77                86(42%)               Cytoplasm                      Cytoskeleton, regulation of muscle contraction        c, l
                  5              P06748              Nucleophosmin, B23                            33.026/4.6                 54(34%)               Nucleus                        Regulate cell proliferation                           a
                  6              NP 004491           Heterogeneous nuclear ribonucleoprotein C     27.861/4.55                117(59%)              Nucleus                        mRNA processing                                       d, h
                  7              P60709              Actin β subunit                               40.536/5.55                63(40%)               Cytoskeleton                   Cytoskeleton                                          c, l
                  8              P60709              Actin β chain                                 41.321/5.56                114(58%)              Cytoskeleton                   Cytoskeleton                                          c, l
                  9              NP 001606           Actin-gamma                                   42.108/5.31                57(39%)               Cytoplasm                      Cytoskeleton, cell motility                           c, l
                  10             NP 057078           H^+^-transporting two-sector ATPase           56.525/5.26                132(53%)              Mitochondrion                  ATP synthesis coupled proton transport                k
                  11             NP 001677           H^+^-transporting two-sector ATPase β chain   56.525/5.26                170(65%)              Mitochondrion                  ATP synthesis coupled proton transport                k
  **Cells**       **SpotNO.**    **Accession NO.**   **Identification**                            **Theoretical M.W./ PI**   **Score (Seq Cov)**   **Cellular localization**      **Molecular function**                                **Class.**
                  12             P20100              Lamin B1                                      66.522/5.11                273(53%)              Nucleus                        Structure protein                                     l
                  13             P20100              Lamin B1                                      66.522/5.11                256(58%)              Nucleus                        Structure protein                                     l
  **SK-Hep--1**                                                                                                                                                                                                                          
                  14             AAK01919            mAb 3H11 antigen                              69.954/5.19                66(24%)               Nucleus/ cytoplasm             Protein binding                                       k
                  15                                 ND                                                                                                                                                                                  
                  16                                 ND                                                                                                                                                                                  
                  17             P08670              Vimentin                                      49.680/5.19                211(62%)              Cytoskeleton                   Cytoskeleton, cell motility                           c, f, l
                  18             P08670              Vimentin                                      49.680/5.19                204(66%)              Cytoskeleton                   Cytoskeleton, cell motility                           c, f, l
                  19             P20100              Lamin B1                                      66.522/5.11                186(54%)              Nucleus                        Structure protein                                     l
                  20             NP 112533           Heterogeneous nucleus ribonucleoprotein B1    37.464/8.97                                      Nucleus                        mRNA processing                                       d, h
  --------------- -------------- ------------------- --------------------------------------------- -------------------------- --------------------- ------------------------------ ----------------------------------------------------- ------------

ND: None detected.

**The functional classification (Class)** of identified proteins is shown a \~ m. a: cell cycle; b: chaperone/ stress response; c: cytoskeleton/ cell mobility; d: DNA replication/ gene regulation/ cell proliferation; e: ion channels; f: membrane proteins; g: metabolic enzyme; h: protection and detoxification; i: protein synthesis and degradation; j: signal transduction; k: transport/ binding proteins; l: intermediate filaments; m: unannotated/ function inferred.

10.1371/journal.pone.0139232.t005

###### List of unregulated proteins in the 2DE map of either the well-differentiated HepG2 cells or the poorly differentiated SK-Hep--1 cells identified by MALDI-TOF MS.
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  Cellular compartemts    Spot No   Association code   Name                                         Theoretical (kDa)/pI   HepG2   SK-Hep--1   Fold   Cellular localization   Function
  ----------------------- --------- ------------------ -------------------------------------------- ---------------------- ------- ----------- ------ ----------------------- ----------------------------------------------------
  **Total Cell lysate**   1         NP005887           NADP^+^-dependent isocitrate dehydrogenase   46.944/6.34            ↑       ↓           0.01   Mitochondria            Metabolic enzyme in TCA cycle
                          2         P32119             Peroxiredoxin II                             21.918/5.67            ↑       ↓           0.27   Cytoplasm               Antioxidant enzyme
                          3         NP003350           UDP-glucose dehydrogenase                    55.674/6.73            ↑       ↓           0.19   Cytoplasm               Metabolic enzyme in Glycosaminoglycan biosynthesis
                          4         P09525             Annexin 4                                    33.757/5.64            ↑       ↓           0.34   Mitochondria            Calcium binding protein
                          5         P33992             Replication licensing factor MCM5            82.990/8.56            ↓       ↑           4.09   Nucleus                 Initiation of DNA replication
                          6         P06753             Tropomyosin3                                 27.386/4.77            ↓       ↑           4.1    Cytoplasm               Cytoskeleton
  **Cytosol**             1         P09525             Annexin 4                                    35.957/5.85            ↑       ↓           0.45   Mitochondria            Calcium binding protein
                          2         NP005887           NADP+-dependent isocitrate dehydrogenase     46.944/6.34            ↑       ↓           0.01   Mitochondria            Metabolic enzyme in TAC cycle
                          3         NP00067            MnSOD                                        22.304/6.86            ↑       ↓           0.2    Mitochondria            Antioxidant enzyme
                          4         NP859048           Peroxiredoxin I                              14.054/6.25            ↑       ↓           0.22   Mitochondria            Antioxidant enzyme
                          5         P32119             Peroxiredoxin II                             21.918/5.67            ↓       ↑           0.6    Cytoplasm               Antioxidant enzyme
                          6         NP003350           UDP-glucose dehydrogenase                    55.674/6.73            ↑       ↓           0.34   Cytoplasm               Glycosaminoglycan
                          7         P04792             Heat Shock Protein 27                        22.427/7.83            ↓       ↑           1.03   Nucleus/ Cytoplasm      Protein folding
                          8         P08670             Vimentin                                     53.545/5.06            ↓       ↑           1.23   Cytoplasm               Cell motility
  **Nucleus**             1         P04083             Annexin 1                                    38.787/6.64            ↓       ↑           4.53   Plasm membrane          Calcium binding protein
                          2         P07355             Annexin 2                                    38.677/7.56            ↓       ↑           3.27   Plasm membrane          Calcium binding protein
                          3         P33991             Replication Licensing factor,MCM4            97.068/6.28            ↓       ↑           1.17   Nucleus                 Initiation of DNA replication biosynthesis
                          4         NP031478           Peroxiredoxin III                            28.047/6.73            ↑       ↓           0.08   Mitochondria            Antioxidant enzyme
  **Membrane**            1         P08670             Vimentin                                     49.680/5.19            ↓       ↑           3.57   Cytoplasm               Cell motility
                          2         P35232             Prohibitin                                   29.859/5.57            ↑       ↓           0.14   Mitochondria            Cell proliferation

10.1371/journal.pone.0139232.t006

###### Summary of the differentially expressed proteins in HepG2 and SK-Hep--1 cells using MALDI-TOF MS and categorized according to their functional roles.
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  Classification                          Identified protein                        Hep-G2              SK-Hep--1
  --------------------------------------- ----------------------------------------- ------------------- ------------------
  Group Ⅰ Intermediate filament           Annexin--1                                \+                  +++++ In nucleus
                                          Annexin--2                                \-                  ++++ In nucleus
                                          Annexin--4                                ++++ In cytoplasm   \+
  Group Ⅱ Protection and detoxification   PeroxiredoxinⅠ                            ++++ In cytoplasm   \+
                                          Peroxiredoxin Ⅱ                           ++++ In cytoplasm   \-
                                          Peroxiredoxin Ⅲ                           +++ In nucleus      \-
  Group Ⅲ Cytoskeleton protein            Vimentin                                  \-                  ++++ In membrane
  Group Ⅳ Metabolic enzyme                NADP-dependent Isocitrate dehydrogenase   ++++ In cytoplasm   \-

**Note:** "+" sign denotes positive expression; "-" denotes negative expression

Differential protein spot analysis {#sec016}
----------------------------------

Comparative proteome analysis of various cellular compartments between HepG2 and SK-Hep--1 cells was performed, and 8 protein spots were successfully identified in both cell types. These proteins were classified according to their functional attributes (**Tables [5](#pone.0139232.t005){ref-type="table"} and [6](#pone.0139232.t006){ref-type="table"}**). ANX1 and ANX2 were differentially overexpressed in the nucleus of SK-Hep--1 cells. Conversely, ANX4 was only differentially expressed in the well-differentiated HepG2 cells. Prdx I, II, and III and ICDH were preferentially expressed in the well-differentiated HepG2 cells. Vimentin, an EMT marker, was detected more prominently in SK-Hep--1 cells.

Confirmation of differential expression by immunofluorescence staining and western blotting {#sec017}
-------------------------------------------------------------------------------------------

Using actin, PCNA and Na-K^+^ ATPase as internal controls for the cytosolic, nuclear and membrane fractions, respectively, we confirmed the differential expression of the proteins in various cellular compartments by western blotting. As shown in **[Fig 3](#pone.0139232.g003){ref-type="fig"}**, ANX4 was highly expressed in the cytosolic and nuclear fractions of the well-differentiated HepG2 cells. In contrast, ANX1 and vimentin were overexpressed in the poorly differentiated SK-Hep--1 cells (**[Fig 3](#pone.0139232.g003){ref-type="fig"}**). Immunofluorescence analysis was used to confirm the results of the western blots (**Figs [4](#pone.0139232.g004){ref-type="fig"} and [5](#pone.0139232.g005){ref-type="fig"}**).

![Validation of the differential protein expression between HepG2 and SK-Hep--1 cells by western blot.\
Actin was used as the internal control in the cytosolic fraction (A), PCNA served as the internal control in the nuclear fraction (B), and Na-K+ ATPase was used as the internal control in the membrane fractions (C). (D) C: cytosolic fraction protein, N: nuclear fraction protein, M: membrane fraction protein.](pone.0139232.g003){#pone.0139232.g003}

![Validation of the differential protein expression between HepG2 and SK-Hep--1 cells by immunofluorescence staining.\
The expression patterns of ANX1, ANX4 and Prdx were detected by immunofluorescence staining as described in the Methods and Materials.](pone.0139232.g004){#pone.0139232.g004}

![Expression patterns of differentially expressed proteins identified by comparative proteomic analysis in a panel of five HCC sublines with established differentiation/de-differentiation status.\
The differentiation status (well-differentiated to poorly differentiated) of these five HCC cell lines was on the order of HepG2, Hep3B, HepJ5, Mahlavu, and SK-Hep--1. The expression patterns of ANX1, ANX4, HSP27, Prdx isoforms, vimentin, and fibrinogen were detected by western blotting.](pone.0139232.g005){#pone.0139232.g005}

ANX1 is a biomarker for metastatic potential in HCC cell lines {#sec018}
--------------------------------------------------------------

The differentially expressed protein candidates identified in HepG2 and SK-Hep--1 cells via our proteomic approach are molecular biomarkers of differentiation status. We validated the expression profiles of these proteins using a panel of HCC cells in a descending order of differentiation based on our previous studies\[[@pone.0139232.ref011], [@pone.0139232.ref012]\]. First, ANX1 expression levels progressively increased as HCC cells became less differentiated (**[Fig 6](#pone.0139232.g006){ref-type="fig"}**). The expression profile of vimentin, an EMT marker, was similar to that of ANX1 (**[Fig 6](#pone.0139232.g006){ref-type="fig"}**). In contrast, ANX4 was only overexpressed in the well-differentiated HCC sublines, HepG2 and Hep3B. Because vimentin overexpression is generally recognized as a metastatic phenotype indicator in cancer cells, we hypothesized that ANX1 overexpression may serve a similar functional role in promoting metastasis in HCC cells. To test our hypothesis, we silenced ANX1 expression in HepJ5 cells and demonstrated that this manipulation severely impeded the migration of these cells (**[Fig 6](#pone.0139232.g006){ref-type="fig"}**). This finding strongly suggests that ANX1 and vimentin are involved in the regulation of the metastatic potential of poorly differentiated HCC cells.

![Knockdown of AXN1 expression levels suppressed cell migration.\
AXN1 expression levels were knocked down by transfection of AXN1-specific shRNA into HepJ5 cells as described in the Methods and Materials. (A) The expression levels of AXN1 in control and AXN1-KD cells were determined by real-time PCR and western blotting. (B) The migration of scrambled control and AXN1-KD cells was determined by the transwell migration assay as described in the Methods and Materials.](pone.0139232.g006){#pone.0139232.g006}

Higher HSP27 expression is correlated with a highly metastatic potential in HCC cells {#sec019}
-------------------------------------------------------------------------------------

Consistent with these observations, we also discovered that high expression of HSP27 was correlated with the less differentiated cell types. To confirm the role of HSP27 in HCC cells, we further silenced HSP27 expression by shRNA in SK-Hep--1 cells and performed migration assays. As shown in **[Fig 7](#pone.0139232.g007){ref-type="fig"}**, silencing HSP27 dramatically reduced the migration of SK-Hep--1 cells, indicating that HSP27 expression is critical in modulating the differentiation status of HCC cells.

![Knockdown of HSP27 expression levels suppressed cell migration.\
HSP27 expression levels were knocked down by transfection with HSP27-specific shRNA into SK-Hep--1 cells as described in the Methods and Materials. (A) The expression levels of HSP27 in control and HSP27-KD cells were determined by real-time PCR and western blotting. (B) The migration of scrambled control and HSP27-KD cells was determined by transwell migration assayas described in the Methods and Materials.](pone.0139232.g007){#pone.0139232.g007}

The pathologic characteristics and expression levels of HSP27 and ANX1 {#sec020}
----------------------------------------------------------------------

To understand the correlation between pathologic characteristics and expression levels of HSP 27 and ANX1, the immunohistochemical stains with HSP 27 and ANX1 in tissue microarray sets were performed. As shown in **[Fig 8](#pone.0139232.g008){ref-type="fig"},** HCC was divided into well-differentiated (WD), moderately differentiated (MD) and poorly differentiated (PD). HSP27 expression levels were scored semiquantitatively as weakly positive (1+), moderately positive (2+) and strongly positive (3+). PD HCC tended to express stronger HSP27 than WD HCC (*p*\<0.001) (**[Fig 8A](#pone.0139232.g008){ref-type="fig"}**). MD HCC also revealed stronger HSP27 expression than WD HCC (*p*\<0.05). HSP27 expression was not statistically different between PD HCC and MD HCC. In addition, strong ANX1 expression was more commonly found in PD group compared with WD and MD group (*p*\<0.05 and *p*\<0.01, respectively, **[Fig 8B](#pone.0139232.g008){ref-type="fig"}**).

![The pathologic characteristics and expression levels of HSP 27 and ANX1.\
To understand the correlation between pathologic characteristics and expression levels of HSP 27 and ANX1, the immunohistochemical stains with HSP 27 and ANX1 in HCC tissue microarray were performed. HCC was divided into well-differentiated (WD), moderately differentiated (MD) and poorly differentiated (PD). (A) HSP27 expression levels were scored semiquantitatively as weakly positive (1+), moderately positive (2+) and strongly positive (3+). (B) Expression levels of ANX1 were scored semiquantitatively as negative, weakly positive and strongly positive. The association between pathologic characteristics and ANX1 expression was analyzed.](pone.0139232.g008){#pone.0139232.g008}

Discussion {#sec021}
==========

Previous studies have indicated that the levels of reactive oxygen species (ROS) are significantly higher in many cancer cells than in normal cells. Consequently, cancer cells exhibit higher intrinsic oxidative stress \[[@pone.0139232.ref013], [@pone.0139232.ref022]--[@pone.0139232.ref025]\]. The increased ROS stress in cancer cells is associated with de-differentiation and the acquisition of an invasive phenotype \[[@pone.0139232.ref026], [@pone.0139232.ref027]\]. In our study, well-differentiated HCC cells overexpressed antioxidant/metabolic enzymes, such as MnSOD, Prdx, ICDH, α-enolase and UDP-glucose dehydrogenase (**Tables [5](#pone.0139232.t005){ref-type="table"} and [6](#pone.0139232.t006){ref-type="table"}**). In contrast, poorly differentiated HCC cells exhibited high levels of PDI. Therefore, the intrinsic oxidative stress of HCC cells was modulated through the regulation of antioxidant enzymes and was differentiation status-dependent.

Characteristic changes during EMT include the down-regulation of epithelial markers (e.g., E-cadherin) and the up-regulation of mesenchymal markers, such as vimentin and N-cadherin \[[@pone.0139232.ref028]--[@pone.0139232.ref030]\]. In this study, we initially established that membranous vimentin is abundantly expressed in poorly differentiated SK-Hep--1 cells. In addition, using a panel of five HCC sublines, we demonstrated that vimentin was abundantly expressed in poorly differentiated HCC sublines, including Mahlavu, HepJ5 and SK-Hep--1 cells (**[Fig 5](#pone.0139232.g005){ref-type="fig"}**). These data suggest that the de-differentiation of HCC cells is associated with oxidative stress, which may be the driving force and/or protective mechanism for EMT induction and invasive potential. This notion is supported by the up-regulation in many different cancer cell types of NF-κB, which is responsive to stimuli generated during high intrinsic oxidative stress conditions, such as H~2~O~2~ and GSSG \[[@pone.0139232.ref030], [@pone.0139232.ref031]\]. De-differentiated HCC cells, such as the Mahlavu and SK-Hep--1 sublines, exhibited substantial up-regulation of NFκB (data not shown).

The elevated level of ANX1 detected in poorly differentiated HCC cells, such as Mahlavu and SK-Hep--1 cells, attracted our attention. ANX1 belongs to a family of calcium/phospholipid-binding and actin regulatory proteins. Graauw et al.\[[@pone.0139232.ref032]\]reported that ANX1 and its family member ANX2 are candidate regulators of the oncogene-induced cell morphology switch. During such a switch, tumor cells change from an epithelial to a more migratory, mesenchymal-like phenotype, thus leading to metastasis and the progression of cancer. Our data are consistent with these findings, as the expression pattern of ANX1 was similar to that of vimentin in HCC cells. Increased expression of ANX1 was only observed in poorly differentiated sublines, such as Mahlavu and SK-Hep--1 cells, suggesting that ANX1 is associated with the invasive phenotype (**[Fig 5](#pone.0139232.g005){ref-type="fig"}**). Consistently, down-regulation of ANX1 significantly reduced the migration of invasive HepJ5 cells (**[Fig 6](#pone.0139232.g006){ref-type="fig"}**) and strong ANX1 expression was more commonly found in PD group compared with WD and MD group ([Fig 8B](#pone.0139232.g008){ref-type="fig"}). Those results demonstrates that ANX1 may play a pivotal pole in increasing the metastatic potential of cancer cells and that ANX1 may serve as a biomarker for the aggressive phenotype of HCC cells in conjunction with vimentin.

In contrast to ANX1, ANX4 was uniquely overexpressed in only well-differentiated HCC cells, including the HepG2 and Hep3B sublines. Although the exact role of ANX4 in HCC carcinogenesis remains unclear, Han et al. has suggested that overexpression of ANX4 is associated with paclitaxel resistance in cancer cells \[[@pone.0139232.ref033]\]. Whether ANX4 can also contribute to the acquisition of chemoresistance in HCC cells warrants further investigation.

Finally, among the differentially expressed proteins, the elevated expression of HSP27 was associated with the less differentiated cellular phenotype (**[Fig 5](#pone.0139232.g005){ref-type="fig"}**). Previous studies have indicated that phosphorylation plays a key role in the regulation of HSP27 function and may contribute to the survival of cells during oxidative stress and apoptosis \[[@pone.0139232.ref034], [@pone.0139232.ref035]\]. In addition, HSP27 participates in maintaining GSH in its reduced form during oxidative stress \[[@pone.0139232.ref036]\]. Another study demonstrated that elevated expression of HSP27 is correlated with the enhanced migration of endothelial cells \[[@pone.0139232.ref037]\]. Silencing of HSP27 significantly reduced the migration of invasive SK-Hep--1 cells (**[Fig 7](#pone.0139232.g007){ref-type="fig"}**). Besides, we also demonstrated that PD HCC tended to expression strong HSP27 than WD HCC (*p*\<0.001) (**[Fig 8A](#pone.0139232.g008){ref-type="fig"}**). MD HCC also revealed stronger HSP27 expression than WD HCC (*p*\<0.05). Collectively, these observations suggest that overexpression of HSP27 in de-differentiated HCC cells may be a molecular indicator for HCC metastatic potential.

In conclusion, we have unveiled a group of biomarkers that are relevant to the metastatic status of HCC cells using a proteomic approach and subsequent validation in a panel of five HCC sublines with varying degrees of differentiation. Collectively, a panel of biomarkers, including vimentin, ANX1 and HSP27, were identified as metastatic indicators for HCC cells in our study and may be considered potential therapeutic targets.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: RCW CYH TLP TZP WYC YJC. Performed the experiments: RCW CYH TLP WYC TZL YJC. Analyzed the data: RCW CYH TLP WYC TZL YJC. Contributed reagents/materials/analysis tools: RCW CYH TLP WYC TZL YJC. Wrote the paper: RCW CYH CTH TZL YJC.
